APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cellulose Ethers for Pharmaceutical Sustained-Release Preparations

Compare research editions
View pricing & licenses

Selected research

Industry Research

Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Industry Research Report 2026

24 December 2025120 pages

Choose your research edition.

Industry ResearchCellulose Ethers for Pharmaceutical Sustained-Release Preparations Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Cellulose Ethers for Pharmaceutical Sustained-Release Preparations is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Cellulose Ethers for Pharmaceutical Sustained-Release Preparations is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Cellulose Ethers for Pharmaceutical Sustained-Release Preparations is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Cellulose Ethers for Pharmaceutical Sustained-Release Preparations include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Cellulose Ethers for Pharmaceutical Sustained-Release Preparations.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Market by Company

Ashland

CP Kelco

Shin-Etsu

Luzhou Cellulose

Shandong Ruitai

Shandong Guangda

Shandong Heda Group

Dow

Huzhou Zhanwang

Anhui Sunhere Pharmaceutical Excipients

Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Segment by Type

HPMC

EC

Others

Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Segment by Application

Sustained-Release Preparations

Controlled-Release Preparations

Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cellulose Ethers for Pharmaceutical Sustained-Release Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cellulose Ethers for Pharmaceutical Sustained-Release Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Cellulose Ethers for Pharmaceutical Sustained-Release Preparations manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Cellulose Ethers for Pharmaceutical Sustained-Release Preparations by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Cellulose Ethers for Pharmaceutical Sustained-Release Preparations in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Manufacturers (Tons) & (2021-2026) Table 6. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Market Share by Manufacturers Table 7. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Average Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Manufacturers, Product Type & Application Table 13. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. Ashland Company Information Table 18. Ashland Business Overview Table 19. Ashland Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 20. Ashland Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Product Portfolio Table 21. Ashland Recent Development Table 22. CP Kelco Company Information Table 23. CP Kelco Business Overview Table 24. CP Kelco Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 25. CP Kelco Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Product Portfolio Table 26. CP Kelco Recent Development Table 27. Shin-Etsu Company Information Table 28. Shin-Etsu Business Overview Table 29. Shin-Etsu Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 30. Shin-Etsu Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Product Portfolio Table 31. Shin-Etsu Recent Development Table 32. Luzhou Cellulose Company Information Table 33. Luzhou Cellulose Business Overview Table 34. Luzhou Cellulose Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 35. Luzhou Cellulose Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Product Portfolio Table 36. Luzhou Cellulose Recent Development Table 37. Shandong Ruitai Company Information Table 38. Shandong Ruitai Business Overview Table 39. Shandong Ruitai Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 40. Shandong Ruitai Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Product Portfolio Table 41. Shandong Ruitai Recent Development Table 42. Shandong Guangda Company Information Table 43. Shandong Guangda Business Overview Table 44. Shandong Guangda Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Shandong Guangda Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Product Portfolio Table 46. Shandong Guangda Recent Development Table 47. Shandong Heda Group Company Information Table 48. Shandong Heda Group Business Overview Table 49. Shandong Heda Group Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 50. Shandong Heda Group Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Product Portfolio Table 51. Shandong Heda Group Recent Development Table 52. Dow Company Information Table 53. Dow Business Overview Table 54. Dow Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 55. Dow Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Product Portfolio Table 56. Dow Recent Development Table 57. Huzhou Zhanwang Company Information Table 58. Huzhou Zhanwang Business Overview Table 59. Huzhou Zhanwang Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. Huzhou Zhanwang Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Product Portfolio Table 61. Huzhou Zhanwang Recent Development Table 62. Anhui Sunhere Pharmaceutical Excipients Company Information Table 63. Anhui Sunhere Pharmaceutical Excipients Business Overview Table 64. Anhui Sunhere Pharmaceutical Excipients Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. Anhui Sunhere Pharmaceutical Excipients Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Product Portfolio Table 66. Anhui Sunhere Pharmaceutical Excipients Recent Development Table 67. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Table 68. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Region (2021-2026) & (Tons) Table 69. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Market Share by Region (2021-2026) Table 70. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Forecast by Region (2027-2032) & (Tons) Table 71. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Market Share Forecast by Region (2027-2032) Table 72. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value by Region (2021-2026) & (US$ Million) Table 74. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Market Share by Region (2021-2026) Table 75. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Forecast by Region (2027-2032) & (US$ Million) Table 76. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Market Average Price (US$/Ton) by Region (2021-2026) Table 77. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Market Average Price (US$/Ton) by Region (2027-2032) Table 78. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Table 79. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Region (2021-2026) & (Tons) Table 80. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Market Share by Region (2021-2026) Table 81. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Forecasted Consumption by Region (2027-2032) & (Tons) Table 82. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Forecasted Consumption Market Share by Region (2027-2032) Table 83. North America Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 84. North America Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Country (2021-2026) & (Tons) Table 85. North America Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Country (2027-2032) & (Tons) Table 86. Europe Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 87. Europe Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Country (2021-2026) & (Tons) Table 88. Europe Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Country (2027-2032) & (Tons) Table 89. Asia Pacific Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 90. Asia Pacific Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Country (2021-2026) & (Tons) Table 91. Asia Pacific Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Country (2027-2032) & (Tons) Table 92. South America, Middle East & Africa Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 93. South America, Middle East & Africa Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Country (2021-2026) & (Tons) Table 94. South America, Middle East & Africa Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Country (2027-2032) & (Tons) Table 95. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Type (2021-2026) & (Tons) Table 96. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Type (2027-2032) & (Tons) Table 97. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Market Share by Type (2021-2026) Table 98. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Market Share by Type (2027-2032) Table 99. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value by Type (2021-2026) & (US$ Million) Table 100. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value by Type (2027-2032) & (US$ Million) Table 101. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Market Share by Type (2021-2026) Table 102. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Market Share by Type (2027-2032) Table 103. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Price by Type (2021-2026) & (US$/Ton) Table 104. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Price by Type (2027-2032) & (US$/Ton) Table 105. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Application (2021-2026) & (Tons) Table 106. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Application (2027-2032) & (Tons) Table 107. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Market Share by Application (2021-2026) Table 108. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Market Share by Application (2027-2032) Table 109. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value by Application (2021-2026) & (US$ Million) Table 110. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value by Application (2027-2032) & (US$ Million) Table 111. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Market Share by Application (2021-2026) Table 112. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Market Share by Application (2027-2032) Table 113. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Price by Application (2021-2026) & (US$/Ton) Table 114. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Price by Application (2027-2032) & (US$/Ton) Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Distributors List Table 118. Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Customers List Table 119. Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Industry Trends Table 120. Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Industry Drivers Table 121. Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Industry Restraints Table 122. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. HPMC Product Image Figure 7. EC Product Image Figure 8. Others Product Image Figure 9. Sustained-Release Preparations Product Image Figure 10. Controlled-Release Preparations Product Image Figure 11. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value (2021-2032) & (US$ Million) Figure 13. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Capacity (2021-2032) & (Tons) Figure 14. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production (2021-2032) & (Tons) Figure 15. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Average Price (US$/Ton) & (2021-2032) Figure 16. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Key Manufacturers, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Players Market Share by Production Value in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Figure 20. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value (US$ Million) Growth Rate (2021-2032) Figure 24. Europe Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value (US$ Million) Growth Rate (2021-2032) Figure 25. China Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value (US$ Million) Growth Rate (2021-2032) Figure 26. Japan Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value (US$ Million) Growth Rate (2021-2032) Figure 27. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 30. North America Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Market Share by Country (2021-2032) Figure 31. United States Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 32. United States Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 33. Canada Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 34. Mexico Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 35. Europe Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 36. Europe Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Market Share by Country (2021-2032) Figure 37. Germany Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 38. France Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 39. U.K. Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 40. Italy Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 41. Russia Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 42. Spain Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 43. Netherlands Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 44. Switzerland Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. Sweden Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. Poland Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 47. Asia Pacific Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 48. Asia Pacific Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Market Share by Country (2021-2032) Figure 49. China Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 50. Japan Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 51. South Korea Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. India Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. Australia Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 54. Taiwan Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. Southeast Asia Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 56. South America, Middle East & Africa Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 57. South America, Middle East & Africa Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Market Share by Country (2021-2032) Figure 58. Brazil Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 59. Argentina Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 60. Chile Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 61. Turkey Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 62. GCC Countries Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption and Growth Rate (2021-2032) & (Tons) Figure 63. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Market Share by Type (2021-2032) Figure 64. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Market Share by Type (2021-2032) Figure 65. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Price (US$/Ton) by Type (2021-2032) Figure 66. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Market Share by Application (2021-2032) Figure 67. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Market Share by Application (2021-2032) Figure 68. Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Price (US$/Ton) by Application (2021-2032) Figure 69. Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Value Chain Figure 70. Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Industry Opportunities and Challenges

Scope & coverage.

Types
  • HPMC
  • EC
  • Others
Applications
  • Sustained-Release Preparations
  • Controlled-Release Preparations
Companies covered
  • Ashland
  • CP Kelco
  • Shin-Etsu
  • Luzhou Cellulose
  • Shandong Ruitai
  • Shandong Guangda
  • Shandong Heda Group
  • Dow
  • Huzhou Zhanwang
  • Anhui Sunhere Pharmaceutical Excipients

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Cellulose Ethers for Pharmaceutical Sustained-Release Preparations by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 HPMC
  5. 2.2.3 EC
  6. 2.2.4 Others
  7. 2.3 Cellulose Ethers for Pharmaceutical Sustained-Release Preparations by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  9. 2.3.2 Sustained-Release Preparations
  10. 2.3.3 Controlled-Release Preparations
  11. 2.4 Global Market Growth Prospects
  12. 2.4.1 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Estimates and Forecasts (2021-2032)
  13. 2.4.2 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Capacity Estimates and Forecasts (2021-2032)
  14. 2.4.3 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Estimates and Forecasts (2021-2032)
  15. 2.4.4 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Manufacturers (2021-2026)
  2. 3.2 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Manufacturers, Product Type & Application
  7. 3.7 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Manufacturers Established Date
  8. 3.8 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Ashland
  2. 4.1.1 Ashland Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Company Information
  3. 4.1.2 Ashland Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Business Overview
  4. 4.1.3 Ashland Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 Ashland Product Portfolio
  6. 4.1.5 Ashland Recent Developments
  7. 4.2 CP Kelco
  8. 4.2.1 CP Kelco Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Company Information
  9. 4.2.2 CP Kelco Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Business Overview
  10. 4.2.3 CP Kelco Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 CP Kelco Product Portfolio
  12. 4.2.5 CP Kelco Recent Developments
  13. 4.3 Shin-Etsu
  14. 4.3.1 Shin-Etsu Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Company Information
  15. 4.3.2 Shin-Etsu Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Business Overview
  16. 4.3.3 Shin-Etsu Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 Shin-Etsu Product Portfolio
  18. 4.3.5 Shin-Etsu Recent Developments
  19. 4.4 Luzhou Cellulose
  20. 4.4.1 Luzhou Cellulose Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Company Information
  21. 4.4.2 Luzhou Cellulose Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Business Overview
  22. 4.4.3 Luzhou Cellulose Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 Luzhou Cellulose Product Portfolio
  24. 4.4.5 Luzhou Cellulose Recent Developments
  25. 4.5 Shandong Ruitai
  26. 4.5.1 Shandong Ruitai Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Company Information
  27. 4.5.2 Shandong Ruitai Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Business Overview
  28. 4.5.3 Shandong Ruitai Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 Shandong Ruitai Product Portfolio
  30. 4.5.5 Shandong Ruitai Recent Developments
  31. 4.6 Shandong Guangda
  32. 4.6.1 Shandong Guangda Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Company Information
  33. 4.6.2 Shandong Guangda Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Business Overview
  34. 4.6.3 Shandong Guangda Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 Shandong Guangda Product Portfolio
  36. 4.6.5 Shandong Guangda Recent Developments
  37. 4.7 Shandong Heda Group
  38. 4.7.1 Shandong Heda Group Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Company Information
  39. 4.7.2 Shandong Heda Group Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Business Overview
  40. 4.7.3 Shandong Heda Group Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 Shandong Heda Group Product Portfolio
  42. 4.7.5 Shandong Heda Group Recent Developments
  43. 4.8 Dow
  44. 4.8.1 Dow Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Company Information
  45. 4.8.2 Dow Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Business Overview
  46. 4.8.3 Dow Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 Dow Product Portfolio
  48. 4.8.5 Dow Recent Developments
  49. 4.9 Huzhou Zhanwang
  50. 4.9.1 Huzhou Zhanwang Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Company Information
  51. 4.9.2 Huzhou Zhanwang Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Business Overview
  52. 4.9.3 Huzhou Zhanwang Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 Huzhou Zhanwang Product Portfolio
  54. 4.9.5 Huzhou Zhanwang Recent Developments
  55. 4.10 Anhui Sunhere Pharmaceutical Excipients
  56. 4.10.1 Anhui Sunhere Pharmaceutical Excipients Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Company Information
  57. 4.10.2 Anhui Sunhere Pharmaceutical Excipients Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Business Overview
  58. 4.10.3 Anhui Sunhere Pharmaceutical Excipients Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Capacity, Value and Gross Margin (2021-2026)
  59. 4.10.4 Anhui Sunhere Pharmaceutical Excipients Product Portfolio
  60. 4.10.5 Anhui Sunhere Pharmaceutical Excipients Recent Developments
5 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Region
  1. 5.1 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Region: 2021-2032
  3. 5.2.1 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Region: 2021-2026
  4. 5.2.2 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Forecast by Region (2027-2032)
  5. 5.3 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value by Region: 2021-2032
  7. 5.4.1 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value by Region: 2021-2026
  8. 5.4.2 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production and Value, YOY Growth
  11. 5.6.1 North America Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Estimates and Forecasts (2021-2032)
6 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Region
  1. 6.1 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Region (2021-2032)
  3. 6.2.1 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Region: 2021-2026
  4. 6.2.2 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Type (2021-2032)
  2. 7.1.1 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Type (2021-2032) & (Tons)
  3. 7.1.2 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Market Share by Type (2021-2032)
  4. 7.2 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value by Type (2021-2032)
  5. 7.2.1 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Application (2021-2032)
  2. 8.1.1 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production by Application (2021-2032) & (Tons)
  3. 8.1.2 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Market Share by Application (2021-2032)
  4. 8.2 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value by Application (2021-2032)
  5. 8.2.1 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Value Chain Analysis
  2. 9.1.1 Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Production Mode & Process
  5. 9.2 Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Distributors
  8. 9.2.3 Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Customers
10 Global Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Analyzing Market Dynamics
  1. 10.1 Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Industry Trends
  2. 10.2 Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Industry Drivers
  3. 10.3 Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Industry Opportunities and Challenges
  4. 10.4 Cellulose Ethers for Pharmaceutical Sustained-Release Preparations Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst